What caused the TMD.TO stock spike today?

The intraday spike was driven by a volume surge to **117,220** shares. No major company release matched the timing. Market attention, speculative flows, or block trades can produce such moves in thinly traded healthcare micro-caps.

How does Titan Medical's valuation compare to peers?

Titan Medical carries a small market cap of **C$128.30M** and a negative EPS. The Healthcare peer average P/E sits near **14.40**, making Titan’s current metrics inconsistent with sector averages and indicative of higher development risk.

What is Meyka AI's trading view on TMD.TO stock?

Meyka AI rates TMD.TO **64.75/100 (B, HOLD)**. The model projects **C$0.40** versus current **C$1.125**, and flags execution and liquidity risk. This is informational and not investment advice.

How should traders manage risk on TMD.TO trading?

Use tight stop-losses, size positions conservatively, and monitor volume continuity. Given the **2.55x** relative volume, expect quick reversals and thin order books in the TSX-listed Titan Medical shares.

CA Stocks

TMD.TO Titan Medical (TSX) +2149.00% intraday 16 Jan 2026: volume spike to watch

ByDanny Kontos January 17, 2026

TMD.TO stock jumped 2149.00% intraday to C$1.125 on 16 Jan 2026 on a heavy volume surge. The trade volume hit 117,220 shares versus an average of 45,936, driving a move from the open at C$0.05 to a day high of C$1.125. This note reviews what pushed the spike, links fundamentals and technicals, and frames short-term trading risks tied to liquidity and volatility in the TSX-listed medical devices name.